#phaseiib — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #phaseiib, aggregated by home.social.
-
Recognify’s Phase IIb trial of schizophrenia therapy fails to meet primary goal
atai Life Sciences (ATAI) company Recognify Life Sciences has reported that its Phase IIb trial of oral compound,…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Mentalhealth #ataiLifeSciences #CIAS #cognitiveimpairment #cognitivemeasures #Health #LifeSciences #MCCB #MentalHealth #PhaseIIb #RecognifyLifeSciences #schizophrenia #statisticalsignificance
https://www.newsbeep.com/us/47454/ -
Recognify’s Phase IIb trial of schizophrenia therapy fails to meet primary goal
atai Life Sciences (ATAI) company Recognify Life Sciences has reported that its Phase IIb trial of oral compound,…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Mentalhealth #ataiLifeSciences #CIAS #cognitiveimpairment #cognitivemeasures #Health #LifeSciences #MCCB #MentalHealth #PhaseIIb #RecognifyLifeSciences #schizophrenia #statisticalsignificance
https://www.newsbeep.com/us/47454/ -
Recognify’s Phase IIb trial of schizophrenia therapy fails to meet primary goal
atai Life Sciences (ATAI) company Recognify Life Sciences has reported that its Phase IIb trial of oral compound,…
#NewsBeep #News #Mentalhealth #ataiLifeSciences #AU #Australia #CIAS #cognitiveimpairment #cognitivemeasures #Health #LifeSciences #MCCB #MentalHealth #PhaseIIb #RecognifyLifeSciences #Schizophrenia #statisticalsignificance
https://www.newsbeep.com/au/31286/ -
Recognify’s Phase IIb trial of schizophrenia therapy fails to meet primary goal
atai Life Sciences (ATAI) company Recognify Life Sciences has reported that its Phase IIb trial of oral compound,…
#NewsBeep #News #Mentalhealth #ataiLifeSciences #CA #Canada #CIAS #cognitiveimpairment #cognitivemeasures #Health #LifeSciences #MCCB #MentalHealth #PhaseIIb #RecognifyLifeSciences #schizophrenia #statisticalsignificance
https://www.newsbeep.com/ca/33087/ -
https://www.europesays.com/uk/301780/ Recognify’s Phase IIb trial of schizophrenia therapy fails to meet primary goal #AtaiLifeSciences #CIAS #CognitiveImpairment #CognitiveMeasures #Health #LifeSciences #MCCB #MentalHealth #PhaseIIb #RecognifyLifeSciences #schizophrenia #StatisticalSignificance #UK #UnitedKingdom